What departments does Cardiol Therapeutics Inc. have?

Cardiol Therapeutics Inc. has employees across 9 departments including Finance, Legal, Engineering, Information Technology, Operations.

What is the largest department at Cardiol Therapeutics Inc.?

The largest department at Cardiol Therapeutics Inc. is Finance with 2 employees.

Where are Cardiol Therapeutics Inc. employees located globally?

Cardiol Therapeutics Inc. has employees across 2 continents and 3 countries including United Kingdom Of Great Britain And Northern Ireland, Canada, United States Of America.

How has Cardiol Therapeutics Inc.'s team size changed over time?

Cardiol Therapeutics Inc.'s team has remained stable from approximately 23 to 23 employees based on available data.

Cardiol Therapeutics Inc. Employee Directory

Q: Who are Cardiol Therapeutics Inc.'s key employees and leadership?

Cardiol Therapeutics Inc.'s key employees include: President & Ceo/Founder: D. E., Chief Medical Officer: A. H., Chief Financial Officer And Member Of The Board Of Directors: C. W., Chief Ip Counsel: D. K., Vice President Corporate Development: J. A. G..

Biotechnology ResearchOntario, Canada11-50 Employees

Cardiol Therapeutics Inc. is a clinical-stage biotechnology company located in Toronto, Ontario, Canada, operating with a workforce of 11-50 employees at 2265 Upper Middle Road East, Suite 602. The company’s research and development targets heart disease, pursuing anti-inflammatory and anti-fibrotic approaches to address inflammation and fibrosis in conditions such as myocarditis, pericarditis, and heart failure. CardiolRx, its lead drug candidate, is a pharmaceutically manufactured cannabidiol oral solution in clinical development for heart disease, with a mechanism tied to inhibition of inflammasome pathways. The US FDA has granted Investigational New Drug authorization to test CardiolRx in recurrent pericarditis and acute myocarditis, including the MAVERIC program (Phase II MAVERIC-Pilot and Phase III MAVERIC) and the ARCHER Phase II trial; the agency has also designated CardiolRx for orphan drug status in pericarditis. Cardiol is also developing CRD-38, a subcutaneously administered treatment candidate aimed at treating heart failure. The company trades on NASDAQ and TSX under the ticker CRDL.

Cardiol Therapeutics Inc. Global Highlights

North America
26

Canada
23
United States Of America
3

Europe
1

United Kingdom Of Great Britain And Northern Ireland
1

Cardiol Therapeutics Inc.'s Leadership

A. H.
Chief Medical Officer
Mobile Phone
Email
C. W.
Chief Financial Officer And Member Of The Board Of Directors
Mobile Phone
Email
D. K.
Chief Ip Counsel
Mobile Phone
Email
J. A. G.
Vice President Corporate Development
Mobile Phone
Email
D. E.
President & Ceo/Founder
Mobile Phone
Email
D. C.
Director Of Finance
Mobile Phone
Email
M. H.
Director Of Information Technology
Mobile Phone
Email
A. P.
Senior Director, Clinical Operations
Mobile Phone
Email

Cardiol Therapeutics Inc. Employee Metrics

100%

50%

0%

2026

2025

Entrepreneurship
Business
Accounting
Administrative
Business Development
Other
Branding

Contact profiles from Cardiol Therapeutics Inc.

Name

Title

Contact Info

Location

Last Update

A. H.
Chief Medical Officer
Mobile Phone
Email
United StatesNew York
May 19, 2026
C. W.
Chief Financial Officer And Member Of The Board Of Directors
Mobile Phone
Email
CanadaOntario
May 26, 2026
D. E.
President & Ceo/Founder
Mobile Phone
Email
Canada
Jun 03, 2026
D. K.
Chief Ip Counsel
Mobile Phone
Email
CanadaOntario
Apr 14, 2026
J. A. G.
Vice President Corporate Development
Mobile Phone
Email
Canada
Mar 24, 2026
D. C.
Director Of Finance
Mobile Phone
Email
CanadaOntario
Apr 15, 2026
M. H.
Director Of Information Technology
Mobile Phone
Email
Canada
May 22, 2026
A. P.
Senior Director, Clinical Operations
Mobile Phone
Email
CanadaOntario
May 07, 2026
A. B.
Director Of Research
Mobile Phone
Email
United KingdomDerby
May 07, 2026
B. R.
Executive Director
Mobile Phone
Email
Feb 02, 2026

Frequently Asked Questions

What is Cardiol Therapeutics Inc. known for?

Cardiol Therapeutics Inc. was founded in 2017 operates in the Biotechnology Research industry. The company's main headquarters is located in 2265 Upper Middle Road East Suite 602 Toronto, Ontario Canada. Explore Cardiol Therapeutics Inc.'s company overview page for more information.

What is Cardiol Therapeutics Inc.'s most common email format?

Cardiol Therapeutics Inc. employees' email format typically follows the pattern of . Trying to find reliable and up-to-date employee contact data? Find more Cardiol Therapeutics Inc. email formats with LeadIQ.

How many employees does Cardiol Therapeutics Inc. have currently?

Cardiol Therapeutics Inc. has approximately 27 employees as of June 2026. These team members are located across 2 continents, including North AmericaEurope.

Who are Cardiol Therapeutics Inc.'s key employees and leadership?

As of June 2026, Cardiol Therapeutics Inc.'s key employees include:

Chief Medical Officer: A. H.
Chief Financial Officer And Member Of The Board Of Directors: C. W.
Chief Ip Counsel: D. K.
Vice President Corporate Development: J. A. G.
President & Ceo/Founder: D. E.

Looking for contact data? Unlock accurate emails and phone numbers for your ideal prospects with LeadIQ.

Everything for prospecting,
in one platform.

What you can expect from LeadIQ:

B2B data verified in real-time
Sync data to your CRM, & add it to an outreach sequence in one click
Integrations with your tech stack for optimal efficiency
A patented AI cold email generator
Account & contact-level job change tracking

Cardiol Therapeutics Inc. Employee Directory

Find Cardiol Therapeutics Inc. employees' phone numbers or email addresses

Name search is limited — try advanced search instead